Genotype and phenotype correlation in von Hippel-Lindau disease based on alteration of the HIF-α binding site in VHL protein
- PMID: 29595810
- DOI: 10.1038/gim.2017.261
Genotype and phenotype correlation in von Hippel-Lindau disease based on alteration of the HIF-α binding site in VHL protein
Abstract
Purpose: Von Hippel-Lindau (VHL) disease is a rare hereditary cancer syndrome that reduces life expectancy. We aimed to construct a more valuable genotype-phenotype correlation based on alterations in VHL protein (pVHL).
Methods: VHL patients (n = 339) were recruited and grouped based on mutation types: HIF-α binding site missense (HM) mutations, non-HIF-α binding site missense (nHM) mutations, and truncating (TR) mutations. Age-related risks of VHL-associated tumors and patient survival were compared.
Results: Missense mutations conferred an increased risk of pheochromocytoma (HR = 1.854, p = 0.047) compared with truncating mutations. The risk of pheochromocytoma was lower in the HM group than in the nHM group (HR = 0.298, p = 0.003) but was similar between HM and TR groups (HR = 0.901, p = 0.810). Patients in the nHM group had a higher risk of pheochromocytoma (HR = 3.447, p < 0.001) and lower risks of central nervous system hemangioblastoma (CHB) (HR = 0.700, p = 0.045), renal cell carcinoma (HR = 0.610, p = 0.024), and pancreatic tumor (HR = 0.382, p < 0.001) than those in the combined HM and TR (HMTR) group. Moreover, nHM mutations were independently associated with better overall survival (HR = 0.345, p = 0.005) and CHB-specific survival (HR = 0.129, p = 0.005) than HMTR mutations.
Conclusion: The modified genotype-phenotype correlation links VHL gene mutation, substrate binding site, and phenotypic diversity (penetrance and survival), and provides more accurate information for genetic counseling and pathogenesis studies.
Keywords: genotype–phenotype; protein binding site; survival; tumor risk; von Hippel–Lindau disease.
Similar articles
-
Genotype-phenotype analysis of von Hippel-Lindau syndrome in Korean families: HIF-α binding site missense mutations elevate age-specific risk for CNS hemangioblastoma.BMC Med Genet. 2016 Jul 20;17(1):48. doi: 10.1186/s12881-016-0306-2. BMC Med Genet. 2016. PMID: 27439424 Free PMC article.
-
Novel genetic characterisation and phenotype correlation in von Hippel-Lindau (VHL) disease based on the Elongin C binding site: a large retrospective study.J Med Genet. 2020 Nov;57(11):744-751. doi: 10.1136/jmedgenet-2019-106336. Epub 2020 Apr 17. J Med Genet. 2020. PMID: 32303605
-
Genotype-phenotype correlation of ocular von Hippel-Lindau disease in Koreans.PLoS One. 2024 Oct 7;19(10):e0311665. doi: 10.1371/journal.pone.0311665. eCollection 2024. PLoS One. 2024. PMID: 39374255 Free PMC article.
-
The HIF and other quandaries in VHL disease.Oncogene. 2018 Jan 11;37(2):139-147. doi: 10.1038/onc.2017.338. Epub 2017 Sep 18. Oncogene. 2018. PMID: 28925400 Review.
-
von Hippel-Lindau syndrome.Front Horm Res. 2013;41:30-49. doi: 10.1159/000345668. Epub 2013 Mar 19. Front Horm Res. 2013. PMID: 23652669 Review.
Cited by
-
Tumorigenesis Mechanisms Found in Hereditary Renal Cell Carcinoma: A Review.Genes (Basel). 2022 Nov 15;13(11):2122. doi: 10.3390/genes13112122. Genes (Basel). 2022. PMID: 36421797 Free PMC article. Review.
-
Cardio-onco-metabolism: metabolic remodelling in cardiovascular disease and cancer.Nat Rev Cardiol. 2022 Jun;19(6):414-425. doi: 10.1038/s41569-022-00698-6. Epub 2022 Apr 19. Nat Rev Cardiol. 2022. PMID: 35440740 Free PMC article. Review.
-
Intra-Familial Phenotypic Heterogeneity and Telomere Abnormality in von Hippel- Lindau Disease: Implications for Personalized Surveillance Plan and Pathogenesis of VHL-Associated Tumors.Front Genet. 2019 Apr 24;10:358. doi: 10.3389/fgene.2019.00358. eCollection 2019. Front Genet. 2019. PMID: 31068970 Free PMC article.
-
Clinical and Genetic Characteristics of Retinal Capillary Hemangioblastoma in Korean Patients.Korean J Ophthalmol. 2022 Dec;36(6):543-549. doi: 10.3341/kjo.2022.0079. Epub 2022 Oct 25. Korean J Ophthalmol. 2022. PMID: 36281577 Free PMC article.
-
Algorithmic assessment of missense mutation severity in the Von-Hippel Lindau protein.PLoS One. 2020 Nov 5;15(11):e0234100. doi: 10.1371/journal.pone.0234100. eCollection 2020. PLoS One. 2020. PMID: 33151962 Free PMC article.
References
-
- Gossage L, Eisen T, Maher ER. VHL, the story of a tumour suppressor gene. Nat Rev Cancer 2015;15:55–64. - DOI
-
- Maher ER, Neumann HP, Richard S. von Hippel-Lindau disease: a clinical and scientific review. Eur J Hum Genet 2011;19:617–623. - DOI
-
- Chou A, Toon C, Pickett J, Gill AJ. von Hippel-Lindau syndrome. Front Horm Res 2013;41:30–49. - DOI
-
- Lonser RR, Glenn GM, Walther M et al. von Hippel-Lindau disease. Lancet 2003;361:2059–2067. - DOI
-
- Nordstrom-O’Brien M, van der Luijt RB, van Rooijen E et al. Genetic analysis of von Hippel-Lindau disease. Hum Mutat 2010;31:521–537. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical